Petlife Pharmaceuticals, Inc.

PTLF · OTC
Analyze with AI
8/31/2017
8/31/2016
8/31/2015
8/31/2014
Operating Activities
Net Income-$23,257-$3,687-$1,936-$1,512
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$21,345$736$1,550$1,245
Change in WC$453$2,793$361$0
Other Non-Cash$1,140$5$1,553$0
Operating Cash Flow-$319-$152-$22-$267
Investing Activities
PP&E Inv.$0$0-$1$0
Net Acquisitions$0$0$0$100
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$1$100
Financing Activities
Debt Repay.$372$153$10$0
Stock Issued$0$0$0$185
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$6-$11
Financing Cash Flow$372$153$16$174
Forex Effect$0$0$0$0
Net Chg. in Cash$53$1-$7$7
Supplemental Information
Beg. Cash$1$0$7$0
End Cash$54$1$0$7
Free Cash Flow-$319-$152-$23-$267